STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
Clinical trials for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE trials appear
Sign up with your email to follow new studies for STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cord blood cells aim to tame deadly transplant complication
Disease control Not yet recruitingThis early-phase trial tests a new treatment called CK0802 for people with severe graft-versus-host disease (GVHD) that does not respond to steroids. GVHD is a serious complication after a bone marrow or stem cell transplant, where donor immune cells attack the patient's body. CK…
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Cellenkos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Stem cell combo shows promise for deadly transplant complication
Disease control Not yet recruitingThis Phase 3 trial tests whether adding a stem cell therapy called remestemcel-L to the drug ruxolitinib can help adults with severe, steroid-resistant graft-versus-host disease (GVHD) after a bone marrow transplant. GVHD occurs when donor immune cells attack the patient's body. …
Matched conditions: STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
Phase: PHASE3 • Sponsor: Mesoblast, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC